Novel Glaucoma Medications: From Clinical Trials to Clinical Experience
Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.